CVS Health (CVS) Set to Announce Earnings on Wednesday

CVS Health (NYSE:CVS) is set to announce its earnings results before the market opens on Wednesday, May 1st. Analysts expect the company to announce earnings of $1.69 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.01 by $0.11. The business had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.99 EPS. On average, analysts expect CVS Health to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

CVS Health Price Performance

CVS Health stock opened at $67.44 on Tuesday. The stock has a market cap of $85.01 billion, a P/E ratio of 10.44, a price-to-earnings-growth ratio of 0.89 and a beta of 0.52. The company has a fifty day simple moving average of $74.22 and a 200-day simple moving average of $73.65. CVS Health has a 12-month low of $64.41 and a 12-month high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.94%. CVS Health’s payout ratio is currently 41.18%.

Insiders Place Their Bets

In other news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.24% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Barclays assumed coverage on shares of CVS Health in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 target price on the stock. StockNews.com lowered CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Cantor Fitzgerald reissued an “overweight” rating and issued a $87.00 target price on shares of CVS Health in a research report on Wednesday, April 10th. Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research report on Monday, February 26th. Finally, SVB Leerink initiated coverage on CVS Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $88.00 price objective for the company. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $89.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.